The Effect of Position on Pain, Bleeding, Hematoma and Vital Signs After Transfemoral Coronary Angiography

ConditionsCoronary Disease Angiography

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorMersin University

About this trial

In this study, it was aimed to determine the effect of the special position given to the patient after transfemoral coronary angiography (supine position that varies depending on the angles) on pain, bleeding, hematoma and vital signs.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Written and verbal permission was obtained to participate in the research.

Able to read, write, speak and understand Turkish

Those who are over 18 years old

Planned transfemoral angiography was performed

Disqualifiers

People with hemophilia or other coagulation defects

Those with active hemorrhage

Previously treated with streptokinase

Using more than 2 anticoagulants or antiplatelets

Trial design

Design model

Parallel

Treatments tested in this trial

Bed Position and Head Elevation
Other intervention
The first group will remain in the supine position for 6 hours after the Angiography procedure, and the treated leg will be kept straight and immobile. Patients will not move their legs during this period. A sandbag weighing approximately 4 kg will be placed over the catheter dressing for 6 hours to prevent bleeding and subcutaneous blood accumulation. For the first two hours, the patient will lie on his back and on a flat surface with his legs extended straight. During the remaining 4 hours, investigators will monitor the patient's bed head by raising it 15 degrees intermittently under the supervision of the doctor, and at the end of the 6th hour, the sandbag on the leg will be removed. Blood pressure, pulse rate, respiratory rate, body temperature, as well as pain level will be measured every two hours.

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: ENTERPRISE GROUPActive comparator 1 intervention

Group B: CONTROL GROUPNo intervention 0 interventions

Trial outcomes

Primary outcomes

Visual Analog Scale

First evaluation criterion after transfemoral coronary angiography is pain. The results will be evaluated using the Visual Analog Scale. "No pain" is rated as 0 points (minimum value) and "very severe pain" is rated as 10 points (maximum value). Pain will decrease as Visual Analog Scale score decreases.

Time frame

Pre-intervention and after the intervention 6 hour.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mersin University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: